Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer

BACKGROUND: Immune checkpoint inhibitors have dramatically changed lung cancer treatment, demonstrating an overall survival benefit. There are limited data about re-challenge in patients with non-small cell lung cancer. We attempted to address this question for re-challenge of immune checkpoint inhi...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Oncotarget
मुख्य लेखकों: Niki, Maiko, Nakaya, Aya, Kurata, Takayasu, Yoshioka, Hiroshige, Kaneda, Toshihiko, Kibata, Kayoko, Ogata, Makoto, Nomura, Shosaku
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Impact Journals LLC 2018
विषय:
Research Paper
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6122346/
https://ncbi.nlm.nih.gov/pubmed/30190787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25949
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन